Pfizer, BioNTech start COVID-flu combination vaccine study

Pfizer, BioNTech start COVID-flu combination vaccine study

Source: 
Reuters
snippet: 

U.S. drugmaker Pfizer Inc (PFE.N) and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.